Diagnosis and treatment of primary hyperparathyroidism (20 years of own experience and literature review)
Background. Currently, primary hyperparathyroidism (pHPT) is the third most common endocrine disease after thyroid gland pathology and diabetes mellitus. Untimely diagnosis leads to a severe course of the disease with the development of disabling deformations — osteoporotic fractures, recurrent ston...
Main Authors: | Yu.I. Karachentsev, M.E. Sazonov, V.V. Khaziev, V.N. Dubovik, O.A. Goncharova, I.V. Gopkalova |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaslavsky O.Yu.
2021-09-01
|
Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
Subjects: | |
Online Access: | http://iej.zaslavsky.com.ua/article/view/241515 |
Similar Items
-
Primary hyperparathyroidism: optimize the detection and monitoring (organizational aspects)
by: O.A. Goncharova, et al.
Published: (2022-04-01) -
Associative links between obesity and vitamin D levels as a risk factor for primary hyperparathyroidism
by: O.A. Goncharova, et al.
Published: (2022-05-01) -
EPIDEMIOLOGY OF PRIMARY HYPERPARATHYROIDISM – INVISIBLE PART OF THE ICEBERG (LITERATURE REWIEW)
by: I. A. Baranova, et al.
Published: (2016-06-01) -
Medicinal treatment of primary hyperparathyroidism
by: O.A. Goncharova
Published: (2022-11-01) -
Primary hyperparathyroidism clinical features on endocrinology in-patients clinic
by: I E Sapozhnikova
Published: (2018-10-01)